Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Triamcinolone acetonide

These are related to the Triamcinolone acetonide news, in which you can learn about the latest trends in Triamcinolone acetonide and related information industry, to help you better understand and expand Triamcinolone acetonide market.
  • Drug Patent & Exclusivity Expiration Report - Week of Oct 21 2024

    Drug Patent & Exclusivity Expiration Report - Week of Oct 21 2024

    2024-10-22

    This week, there are 3 drugs in the patent and exclusivity list. They are: - BRISTOL-MYERS SQUIBB CO's ABRAXANE, containing active ingredient PACLITAXEL - VERTEX PHARMACEUTICALS INC's TRIKAFTA (COPACKAGED), containing active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - BAUSCH AND LOMB INC's XIPERE, containing active ingredient TRIAMCINOLONE ACETONIDE Read More